Next to direct GH-/IGF1-induced effects, other factors such as vitamin D deficiency, hypogonadism and aggressive replacement of hypopituitarism, especially of glucocorticoids, contribute to the skeletal fragility of patients with acromegaly [1]. This evidence concerns the gene GH1 and acromegaly.